Trinity Biotech plc Interest Expense 2011-2026 | TRIB

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Trinity Biotech plc

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	6.75 M	6.58 M	5.08 M	5.4 M	5.44 M	4.05 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
6.75 M	4.05 M	5.55 M

Interest Expense of other stocks in the Diagnostics research industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	8.42 M	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	81 M	$ 116.13	0.51 %	$ 35.3 B	USA
Akumin AKU	118 M	-	-17.87 %	$ 25.9 M	Canada
Accelerate Diagnostics AXDX	235 K	-	-61.36 %	$ 2.46 M	USA
Co-Diagnostics CODX	106 K	$ 1.64	-1.8 %	$ 2.18 M	USA
Aspira Women's Health AWH	1.81 M	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	316 K	-	-13.05 %	$ 7.29 M	USA
Castle Biosciences CSTL	1 K	$ 25.51	4.29 %	$ 709 M	USA
Chembio Diagnostics CEMI	2.94 K	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	13 K	-	-	$ 9.42 M	Israel
CareDx, Inc CDNA	524 K	$ 21.53	1.39 %	$ 1.15 B	USA
DermTech DMTK	-355 K	-	-11.32 %	$ 2.94 M	USA
Enzo Biochem ENZ	494 K	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	18.6 M	-	-	$ 19.8 B	USA
Illumina ILMN	-292 M	$ 127.88	-	$ 20.3 B	USA
Fulgent Genetics FLGT	561 K	$ 15.96	-2.15 %	$ 483 M	USA
Global Cord Blood Corporation CO	6.27 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	15.2 K	-	-	$ 7.1 B	Australia
Charles River Laboratories International CRL	-22.6 M	$ 173.08	1.95 %	$ 8.58 B	USA
Guardant Health GH	-10.5 M	$ 90.12	1.36 %	$ 11.3 B	USA
Lantheus Holdings LNTH	31.3 M	$ 83.88	-0.53 %	$ 5.66 B	USA
Medpace Holdings MEDP	-5.34 M	$ 415.61	1.23 %	$ 12 B	USA
HTG Molecular Diagnostics HTGM	857 K	-	-20.0 %	$ 1.06 M	USA
Heska Corporation HSKA	4.19 M	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	-252 K	$ 1.91	-3.29 %	$ 8.45 M	USA
Koninklijke Philips N.V. PHG	288 M	$ 27.57	0.35 %	$ 20 B	Niderland
Motus GI Holdings MOTS	211	-	-34.28 %	$ 263 K	Israel
Senseonics Holdings SENS	-23 K	$ 7.04	-0.14 %	$ 294 M	USA
QIAGEN N.V. QGEN	-6.65 M	-	-	$ 10.6 B	Niderland
Neogen Corporation NEOG	38.1 M	$ 9.49	-0.47 %	$ 2.06 B	USA
Soleno Therapeutics SLNO	110 K	$ 52.73	0.01 %	$ 2.68 B	USA
Biomerica BMRA	367	$ 2.14	-	$ 4.92 M	USA
National Research Corporation NRC	-95 K	$ 17.17	-0.35 %	$ 384 M	USA
ICON Public Limited Company ICLR	337 M	$ 100.45	-1.68 %	$ 8.29 B	Irlanda
Laboratory Corporation of America Holdings LH	224 M	$ 263.57	-0.06 %	$ 21.9 B	USA
Thermo Fisher Scientific TMO	-12 M	$ 470.21	0.14 %	$ 177 B	USA
Celcuity CELC	2.11 M	$ 124.3	2.7 %	$ 5.81 B	USA
OpGen OPGN	7.56 K	-	-16.95 %	$ 1.54 M	USA
NeoGenomics NEO	296 K	$ 8.46	1.99 %	$ 1.08 B	USA
Twist Bioscience Corporation TWST	-903 K	$ 60.08	-1.41 %	$ 3.59 B	USA
Myriad Genetics MYGN	800 K	$ 4.75	-0.73 %	$ 440 M	USA
Natera NTRA	9.32 M	$ 206.37	1.29 %	$ 20.3 B	USA
Quest Diagnostics Incorporated DGX	26 M	$ 197.17	0.49 %	$ 21.9 B	USA
Invitae Corporation NVTA	56.7 M	-	-	$ 21.2 M	USA
PerkinElmer PKI	-3.36 M	-	-0.91 %	$ 14.7 B	USA